Neurociencias
Departamento
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublicacións en colaboración con investigadores/as de Pharmacoeconomics and Outcomes Research Iberia (2)
2012
-
Budgetary impact analysis of buprenorphine-naloxone combination (suboxone®) in Spain
Health Economics Review, Vol. 2, Núm. 1, pp. 1-9
2010
-
Suboxone® (buprenorphine/naloxone) as an agonist opioid treatment in Spain: A budgetary impact analysis
European Addiction Research, Vol. 16, Núm. 1, pp. 31-42